Anastrozole may be superior to Tamoxifen as adjuvant treatment for postmenopausal patients with breast cancer

Maxine D. Fisher, Joyce O'Shaughnessy, Joseph A. Sparano

Research output: Contribution to journalArticle

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)269-271
Number of pages3
JournalClinical Breast Cancer
Volume2
Issue number4
StatePublished - 2002
Externally publishedYes

Fingerprint

Tamoxifen
Breast Neoplasms
Therapeutics
anastrozole

ASJC Scopus subject areas

  • Cancer Research

Cite this

Anastrozole may be superior to Tamoxifen as adjuvant treatment for postmenopausal patients with breast cancer. / Fisher, Maxine D.; O'Shaughnessy, Joyce; Sparano, Joseph A.

In: Clinical Breast Cancer, Vol. 2, No. 4, 2002, p. 269-271.

Research output: Contribution to journalArticle

@article{6b9f2a7311d74f10802e698fa45a5946,
title = "Anastrozole may be superior to Tamoxifen as adjuvant treatment for postmenopausal patients with breast cancer",
author = "Fisher, {Maxine D.} and Joyce O'Shaughnessy and Sparano, {Joseph A.}",
year = "2002",
language = "English (US)",
volume = "2",
pages = "269--271",
journal = "Clinical Breast Cancer",
issn = "1526-8209",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Anastrozole may be superior to Tamoxifen as adjuvant treatment for postmenopausal patients with breast cancer

AU - Fisher, Maxine D.

AU - O'Shaughnessy, Joyce

AU - Sparano, Joseph A.

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0036185039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036185039&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0036185039

VL - 2

SP - 269

EP - 271

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

SN - 1526-8209

IS - 4

ER -